Genetic causes of mild hyperhomocysteinemia in patients with premature occlusive coronary artery diseases

被引:106
作者
Tsai, MY
Welge, BG
Hanson, NQ
Bignell, MK
Vessey, J
Schwichtenberg, K
Yang, F
Bullemer, FE
Rasmussen, R
Graham, KJ
机构
[1] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[2] Minneapolis Cardiol Associates, Minneapolis Heart Inst, Minneapolis, MN 55407 USA
[3] Univ Minnesota, Sch Med, Dept Epidemiol, Minneapolis, MN 55455 USA
关键词
cardiovascular diseases; homocysteine; methionine load; cystathionine beta-synthase; methylenetetrahydrofolate reductase; methionine synthase; B vitamins;
D O I
10.1016/S0021-9150(98)00271-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Elevated plasma homocysteine is increasingly being recognized as a risk factor for coronary artery disease (CAD). Although there is general agreement on the importance of micronutrients and genetic predisposition to elevated plasma homocysteine, the exact influence of the known prevalent mutations in genes which regulate homocysteine metabolism is not clear. We studied 376 cases of individuals with premature CAD with respect to their fasting and post-methionine load (PML) total homocysteine (tHcy) concentrations. We also determined the presence or absence of the T833C and G(919)A mutations of the cystathionine-beta-synthase (CBS) gene, the C677T mutation of the methylene tetrahydrofolate reductase (MTHFR) gene, and the A(2756)G transition of the B-12 dependent methionine synthase (MS) gene. Our objectives were therefore both to confirm the relationship of plasma homocysteine with premature CAD and to examine the importance of genetic influence on both fasting and PML homocysteine. Approximately 32% of the CAD patients had fasting hyperhomocysteinemia and 16% had PML hyperhomocysteinemia. Of these, 8.5% had both forms of hyperhomocysteinemia (combined hyperhomocysteinemia). The T833C mutation in the CBS gene and the thermolabile C677T mutation in the MTHFR gene seem to play an important role in the subset of individuals with combined hyperhomocysteinemia. The A(2756)G transition in the MS gene is not associated with elevated plasma tHcy. Many cases (47%) of hyperhomocysteinemia are not associated with micronutrient deficiencies, impaired renal function, and/or currently known genetic mutations. Further work is needed to study whether unknown mutations, particularly those residing in the intronic sequences of the genes involved in homocysteine metabolism, other environmental factors, or interaction of gene, nutrient, and environmental factors may be the cause of currently unexplained cases of mild hyperhomocysteinemia. (C) 1999 Published by Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:163 / 170
页数:8
相关论文
共 34 条
  • [1] SERUM TOTAL HOMOCYSTEINE AND CORONARY HEART-DISEASE
    ARNESEN, E
    REFSUM, H
    BONAA, KH
    UELAND, PM
    FORDE, OH
    NORDREHAUG, JE
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1995, 24 (04) : 704 - 709
  • [2] HETEROZYGOSITY FOR HOMOCYSTINURIA IN PREMATURE PERIPHERAL AND CEREBRAL OCCLUSIVE ARTERIAL-DISEASE
    BOERS, GHJ
    SMALS, AGH
    TRIJBELS, FJM
    FOWLER, B
    BAKKEREN, JAJM
    SCHOONDERWALDT, HC
    KLEIJER, WJ
    KLOPPENBORG, PWC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (12) : 709 - 715
  • [3] Excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients
    Bostom, AG
    Gohh, RY
    Tsai, MY
    HopkinsGarcia, BJ
    Nadeau, MR
    Bianchi, LA
    Jacques, PF
    Rosenberg, IH
    Selhub, J
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (10) : 1894 - 1900
  • [4] BOSTOM AG, 1995, IRISH J MED SCI S15, V164, P3
  • [5] BRATTSTROM L, 1989, HAEMOSTASIS, V19, P35
  • [6] A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction
    Brugada, R
    Marian, AJ
    [J]. ATHEROSCLEROSIS, 1997, 128 (01) : 107 - 112
  • [7] CHEN LH, 1997, J BIOL CHEM, V272, P3728
  • [8] Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease
    Christensen, B
    Frosst, P
    LussierCacan, S
    Selhub, J
    Goyette, P
    Rosenblatt, DS
    Genest, J
    Rozen, R
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (03) : 569 - 573
  • [9] HYPERHOMOCYSTEINEMIA - AN INDEPENDENT RISK FACTOR FOR VASCULAR-DISEASE
    CLARKE, R
    DALY, L
    ROBINSON, K
    NAUGHTEN, E
    CAHALANE, S
    FOWLER, B
    GRAHAM, I
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) : 1149 - 1155
  • [10] ENGBERSEN AMT, 1995, AM J HUM GENET, V56, P142